Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
By M. Lehtinen, J. Paavonen, C. Wheeler, U. Jaisamrarn, Suzanne M. Garland, X. Castellsagué, S. Skinner, D. Apter, P. Naud, J. Salmerón and 20 more. The Lancet Oncology, 2012
631 citations recorded by the source corpus.
Subfields: Epidemiology, Microbiology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/e4ddc3a479fac27caaad152669fb7b506028d7e9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Otorhinolaryngology
Citations in the corpus
- A review of clinical trials of human papillomavirus prophylactic vaccines. (2012, methodology): “Similar trends were seen in the Cervarix® efficacy trials [23].”